Clinical Trial Update: An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer [Phase 2]

View source ↗

Summary

Pfizer conducted an international Phase 2 trial of SU011248 in patients with unresectable hepatocellular carcinoma; the study has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SU011248

Snippet

Sponsor: Pfizer | Conditions: Liver Neoplasms, Unresectable Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2010-02-02